APOE epsilon 4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

Elles Konijnenberg, Betty M. Tijms*, Johan Gobom, Valerija Dobricic, Isabelle Bos, Stephanie Vos, Magda Tsolaki, Frans Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleo, Lutz Froelich, Simon Lovestone, Johannes Streffer, Lars Bertram, Kaj Blennow, Charlotte E. Teunissen, Robert Veerhuis, August B. SmitPhilip Scheltens, Henrik Zetterberg, Pieter Jelle Visser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number65
Number of pages11
JournalAlzheimer's Research & Therapy
Volume12
Issue number1
DOIs
Publication statusPublished - 27 May 2020

Keywords

  • Amyloid aggregation
  • APOE genotype
  • CSF proteomics
  • APOLIPOPROTEIN E4
  • POSTERIOR CINGULATE
  • BIOMARKERS
  • COMPLEMENT
  • PREVALENCE
  • DEMENTIA
  • ALLELE
  • INFLAMMATION
  • ASSOCIATION
  • MICROGLIA

Cite this

Konijnenberg, E., Tijms, B. M., Gobom, J., Dobricic, V., Bos, I., Vos, S., Tsolaki, M., Verhey, F., Popp, J., Martinez-Lage, P., Vandenberghe, R., Lleo, A., Froelich, L., Lovestone, S., Streffer, J., Bertram, L., Blennow, K., Teunissen, C. E., Veerhuis, R., ... Visser, P. J. (2020). APOE epsilon 4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease. Alzheimer's Research & Therapy, 12(1), [65]. https://doi.org/10.1186/s13195-020-00628-z